Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

09. April 2026 23:06 ET | Quelle: ZenaTech Inc.

ZenaTech anuncia su 21ª adquisición, ampliando su red nacional de Drone como Servicio y su presencia en el noroeste del Pacífico para atender a empresas y gobiernos

VANCOUVER, British Columbia, April 10, 2026 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), proveedor de soluciones tecnológicas especializado en drones con...
09. April 2026 18:51 ET | Quelle: Telix Pharmaceuticals Limited

FDA Accepts NDA for TLX101-Px (Pixclara®)

MELBOURNE, Australia and INDIANAPOLIS, April 10, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the United States (U.S.) Food and Drug...
09. April 2026 18:24 ET | Quelle: Novonix Ltd.

NOVONIX US$103 Million 48C Tax Credits Certified for Synthetic Graphite Facility

U.S. Government has certified NOVONIX's Riverside project in connection with the US$103 million in tax credits.
09. April 2026 18:00 ET | Quelle: Texas Capital Bancshares, Inc.

Texas Capital Bancshares, Inc. Announces Date for Q1 2026 Operating Results

DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- Texas Capital Bancshares, Inc. (NASDAQ: TCBI), the parent company of Texas Capital Bank, today announced that it expects to issue financial results for the...
07. April 2026 04:00 ET | Quelle: Oculis Holding AG

Oculis to Participate in Upcoming Investor Conferences

ZUG, Switzerland, April 07, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis” or the “Company”), a global biopharmaceutical company focused on innovations addressing...